Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.070
-0.090 (-4.17%)
At close: Aug 28, 2026, 4:00 PM EDT
2.063
-0.007 (-0.35%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $26.46 million as of August 28, 2026. Its market cap has decreased by -39.50% in one year.
Market Cap
26.46M
Enterprise Value
19.14M
1-Year Change
-39.50%
Ranking
Category
Stock Price
$2.07
ChartMarket Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $26.46M, a decrease of -12.75%. That is a compound annual growth rate of -2.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 26.46M | -21.91% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 28.25M |
| GridAI Technologies | 28.05M |
| Radiopharm Theranostics | 28.01M |
| NextCure | 27.88M |
| CEL-SCI | 27.44M |
| BeyondSpring | 27.36M |
| Atossa Therapeutics | 25.75M |
| Quantum BioPharma | 25.44M |